Leuven, Belgium

Catherine M Verfaillie

This inventor holds 32 USPTO granted patents and 9 published patent applications and 3 EPO patents, primarily in Stem Cell Research. Top assignees: Regents of the University of Minnesota, Abt Holding Company, Katholieke Universiteit Leuven. Active years: 2006-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Catherine M Verfaillie. Retrieved from https://idiyas.com/inventor/catherine-m-verfaillie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 32 

% Patents Active = 53.1

 

Average Co-Inventor Count = 2.7

ph-index = 10

Forward Citations = 602(Granted Patents)


Location History:

  • White Bear Lake, MN (US) (2011)
  • Lauven, BE (2013)
  • Saint Paul, MN (US) (2006 - 2019)
  • Leuven, BE (2013 - 2022)

Company Filing History:


Years Active: 2006-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
Pluripotent Cells
Hepatic Stellate Cells
Multipotent Adult Stem Cells
Homologous Recombination
Cell Therapy
Differentiation Methods
Endodermal Progenitor Cells
Lysosomal Storage Disorders
Neuronal Differentiation
Myocardial Infarction
Suspension Culture
Cell Aggregates
32 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Catherine M Verfaillie in Stem Cell Research

Introduction: Catherine M Verfaillie, based in Leuven, Belgium, is a prominent inventor known for her significant contributions to the field of stem cell research. With 32 patents to her name, Verfaillie's work focuses on the isolation and differentiation of stem cells, paving the way for advanced therapeutic applications.

Latest Patents: Among her latest innovations, Verfaillie has developed pluripotent cells derived from bone marrow, along with methods for their isolation. This invention provides isolated stem cells of non-embryonic origin that can be maintained in culture in an undifferentiated state or be differentiated into various tissue types. In addition, she has devised methods for differentiating cells into hepatic stellate cells, which are crucial for treating liver deficiencies and conducting liver metabolism studies. These methods lead to the production of cells that express a hepatic stellate phenotype, thereby supporting hepatocyte function and enhancing the understanding of liver-related conditions.

Career Highlights: Throughout her prestigious career, Verfaillie has made impactful contributions while working at respected institutions such as the University of Minnesota and Abt Holding Company. Her research has significantly advanced the field of regenerative medicine, focusing on the therapeutic potentials of stem cells.

Collaborations: Verfaillie has collaborated with notable professionals in her field, including Morayma Reyes and Leo T Furcht, contributing to various projects that promote innovation in stem cell applications and therapies.

Conclusion: Catherine M Verfaillie's innovative inventions and extensive research have positioned her as a key figure in the realm of stem cell science. Her patents reflect her dedication to finding new solutions for pressing medical challenges, enhancing the understanding and treatment of complex conditions related to liver health and tissue regeneration.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…